L-Carnitine vs Meldonium
established vs Moderate Research
avoid Researched · 95% Meldonium and L-carnitine operate through directly opposing mechanisms. Meldonium works by inhibiting carnitine biosynthesis to reduce fatty acid oxidation, while exogenous L-carnitine supplementation aims to enhance fatty acid transport and oxidation. Co-administration would be pharmacologically contradictory, with each agent undermining the other's mechanism of action. Users should choose one approach or the other based on their goals, not combine them.
Molecular Data
L-Carnitine Meldonium
Weight 161.20 Da 146.19 Da
Half-life ~2-3 hours (injectable) ~4-6 hours
Type Quaternary ammonium compound Hydrazinium derivative (C6H14N2O2)
Key Benefits
L-Carnitine
01 Enhanced fatty acid transport to mitochondria
02 Improved energy production from fats
03 Better bioavailability than oral forms
04 Support for exercise recovery
05 Potential cognitive benefits
Meldonium
01 Cardioprotective effects through metabolic optimization under ischemic conditions
02 Shifts cardiac energy metabolism from fatty acid oxidation to more oxygen-efficient glucose oxidation
03 Reduces accumulation of toxic fatty acid intermediates (long-chain acylcarnitines) in heart tissue
04 Promotes nitric oxide synthesis and endothelial function via GBB accumulation
05 May improve exercise capacity and reduce recovery time through enhanced glucose utilization
06 Used as adjunctive cardiac protection during anabolic steroid cycles to mitigate androgen-induced cardiotoxicity
07 Well-established safety profile in Eastern European clinical use spanning over 30 years
Dosing Protocols
L-Carnitine
50-200mg daily / Once daily or pre-workout
Standard Protocol 50-100mg Daily
Advanced Protocol 100-200mg Daily
Pre-Workout 100-200mg 30-60 min before exercise
Meldonium
500-1000 mg/day / Once or twice daily (oral)
Side Effects
L-Carnitine
Injection site reactions
Mild nausea
Body odor (fishy smell at high doses)
Meldonium
Mild gastrointestinal discomfort (nausea, dyspepsia, or stomach upset -- typically transient and dose-dependent)
Occasional heartburn or acid reflux, especially at higher doses or when taken on an empty stomach
Contraindications
Seizure disorders (may lower seizure threshold)
Hypothyroidism (may affect thyroid function)
Allergy to carnitine products
Known hypersensitivity to meldonium or any excipients
Pregnancy or breastfeeding (insufficient safety data)
Individuals under 18 years of age
Severe hepatic or renal impairment (limited pharmacokinetic data in these populations)
Increased intracranial pressure (listed as a contraindication in some regional prescribing information)
Research Evidence
L-Carnitine Meldonium
Status established Moderate Research
References 2 studies 4 studies
Latest — 2016
FDA Approved Yes No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.